Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

SHBG may be a useful early indicator and treatment target for PCOS.

Men with early hair loss have lower vitamin D levels.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

Skin issues are common and important for diagnosing PCOS.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.